These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2868094)

  • 1. Drug delivery to the proximal colon.
    Hardy JG; Wilson CG; Wood E
    J Pharm Pharmacol; 1985 Dec; 37(12):874-7. PubMed ID: 2868094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-bowel transit in patients with the irritable bowel syndrome.
    Hardy JG; Wood E; Clark AG; Reynolds JR
    Eur J Nucl Med; 1986; 11(10):393-6. PubMed ID: 3699063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
    Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
    Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
    Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
    J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for preparing radioactive capsules in colon transit study.
    Wang SJ; Tsai SC; Lin WY; Chen GH
    Eur J Nucl Med; 2000 Jul; 27(7):857-60. PubMed ID: 10952498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of capsule size and density on transit through the proximal colon.
    Parker G; Wilson CG; Hardy JG
    J Pharm Pharmacol; 1988 May; 40(5):376-7. PubMed ID: 2899639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations.
    Hebden JM; Gilchrist PJ; Blackshaw E; Frier ME; Perkins AC; Wilson CG; Spiller RC
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1379-85. PubMed ID: 10654798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
    Asghar LF; Chandran S
    J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of aminophylline delivered to the small intestine and colon using remote controlled capsules.
    Liu HY; Pi XT; Zheng XL; Hou WS; Cui JG
    Chin Med J (Engl); 2010 Feb; 123(3):320-5. PubMed ID: 20193253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transit of pharmaceutical dosage forms through the small intestine.
    Davis SS; Hardy JG; Fara JW
    Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-specific drug release to the colon.
    Jain SK; Jain A
    Expert Opin Drug Deliv; 2008 May; 5(5):483-98. PubMed ID: 18491977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of a novel capsule for colon-specific drug delivery.
    Han M; Fang QL; Zhan HW; Luo T; Liang WQ; Gao JQ
    J Pharm Sci; 2009 Aug; 98(8):2626-35. PubMed ID: 19067397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog.
    Parr AF; Sandefer EP; Wissel P; McCartney M; McClain C; Ryo UY; Digenis GA
    Pharm Res; 1999 Feb; 16(2):266-71. PubMed ID: 10100313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
    Green JT; Evans BK; Rhodes J; Thomas GA; Ranshaw C; Feyerabend C; Russell MA
    Br J Clin Pharmacol; 1999 Oct; 48(4):485-93. PubMed ID: 10583017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic drug delivery: an updated review.
    Shareef MA; Khar RK; Ahuja A; Ahmad FJ; Raghava S
    AAPS PharmSci; 2003; 5(2):E17. PubMed ID: 12866944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of colonic transit using a delayed-release capsule containing radio-opaque markers.
    Park JM; Choi MG; Choi H; Cho YK; Oh JH; Lee IS; Kim SW; Choi KY; Chung IS
    Scand J Gastroenterol; 2008; 43(5):545-50. PubMed ID: 18415746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transit through the proximal colon influences stool weight in the irritable bowel syndrome.
    Vassallo M; Camilleri M; Phillips SF; Brown ML; Chapman NJ; Thomforde GM
    Gastroenterology; 1992 Jan; 102(1):102-8. PubMed ID: 1727743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
    Asghar LF; Azeemuddin M; Jain V; Chandran S
    Drug Deliv; 2009 May; 16(4):205-13. PubMed ID: 19514981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroretentive microparticles for drug delivery applications.
    Adebisi A; Conway BR
    J Microencapsul; 2011; 28(8):689-708. PubMed ID: 21726124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.